MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics

Positive

AI Analysis

Summary

MapLight Therapeutics celebrates co-founder Dr. Karl Deisseroth's receipt of the 2026 Nobel Prize in Physiology or Medicine for developing optogenetics technology.

Importance:3/10

Sentiment:

0.80

nobel_prizeoptogeneticsco-founderaward

Related Companies

$MPLT

Read the original article

Published by yahoo_finance on October 6, 2026 11:00 AM

Read Original